
TELA Bio Investor Relations Material
Latest events

Q2 2025
TELA Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from TELA Bio Inc
Access all reports
TELA Bio Inc. is a medical technology company focused on developing and commercializing soft tissue reconstruction solutions. The company specializes in biologic and synthetic materials used in surgeries for hernia repair and abdominal wall reconstruction. TELA Bio’s products are designed to provide improved clinical outcomes by combining the strength of synthetic materials with the regenerative properties of biologic tissues. The company serves surgeons and healthcare providers, offering solutions that aim to enhance patient recovery and reduce complications. The company is headquartered in Malvern, Pennsylvania, and its shares are listed on the NASDAQ.
Key slides for TELA Bio Inc


Investor Presentation
TELA Bio Inc


Investor Presentation
TELA Bio Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
TELA
Country
🇺🇸 United States